Weight Loss News and Research

Latest Weight Loss News and Research

Mediterranean Diet beneficial even without weight loss

The benefits of the Mediterranean Diet go beyond weight loss, even when weight loss isn't achieved. Researchers from St. Vincent's Hospital, Melbourne, studied 12 patients without diabetes who had nonalcoholic fatty liver disease (NAFLD), and the results of their study demonstrated that liver health was improved even without weight loss.

7 Nov 2011

Largest-ever implementation study on kala-azar in Asia

A comprehensive four-year project including over 10,000 patients in clinical and pharmacovigilance studies for diagnosis and treatment of visceral leishmaniasis (VL, also known as kala-azar) in India and Bangladesh was launched by an international consortium formed last month to support control and elimination strategies in both countries, where the concentration of disease burden is among the world's highest.

7 Nov 2011

IntraPace receives CE Mark for new gastric stimulation/food sensing lead

IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.

7 Nov 2011

Researchers discover two effective cancer killers

Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.

7 Nov 2011

Intensive diet, exercise reduce pain and improve mobility in people with knee OA

According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, weight loss combined with exercise reduces pain and improves mobility in people with knee osteoarthritis.

7 Nov 2011

FDA accepts VIVUS' Qnexa NDA for filing and review

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the New Drug Application (NDA) for Qnexa to treat obesity. The company resubmitted the NDA on October 17, 2011.

4 Nov 2011

Exenatide's rapid anti-inflammatory effect may inhibit atherosclerosis

Exenatide, a drug commonly prescribed to help patients with type 2 diabetes improve blood sugar control, also has a powerful and rapid anti-inflammatory effect, a University at Buffalo study has shown.

3 Nov 2011

Combination of Mediterranean diet, physical activity can help improve symptoms of OSAS

Eating a Mediterranean diet combined with physical activity can help to improve some of the symptoms of sleep apnoea, according to new research.

3 Nov 2011

Exercise can prevent inherited obesity & obesity raises injury risk: Two studies

A new study has shown that having an obesity gene should not mean absolute obesity for individuals. The gene may be countered by physical activity.

2 Nov 2011

Reliv third quarter net sales decrease 7.3% to $17.3 million

Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today reported its financial results for the third quarter of 2011.

2 Nov 2011

Positive results from DARA's DB959 Phase 1b study on type 2 diabetes

DARA BioSciences, Inc., announces the positive results from a successfully completed Phase 1b clinical study for DB959, its peroxisome proliferator activated receptor (PPAR)-delta/gamma agonist, a non-TZD oral drug in development for the treatment of type 2 diabetes.

2 Nov 2011

Majority of college students could identify risk factors linked with eating disorders

They're the prime demographic for developing eating disorders, yet new research out of the University of Cincinnati suggests that it could be difficult for college students to notice the warning signs. On Oct. 31, Ashlee Hoffman, a UC doctoral student in health promotion and education, will present her research, titled, "University Students' Knowledge of An Ability to Identify Disordered Eating, Warning Signs and Risk Factors," at the American Public Health Association's 139th annual meeting and exposition in Washington, DC.

1 Nov 2011

Global Health Partner third quarter revenues increase 19% to SEK 129.1M

Global Health Partner: THIRD QUARTER 2011. Revenues increased by 19 percent to SEK 129.1 million.

1 Nov 2011

NPS announces new data from GATTEX Phase 3 study on short bowel syndrome

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced new data from STEPS 2, a long-term open-label study, showing that GATTEX (teduglutide) was associated with achieving and maintaining clinically meaningful reductions in parenteral nutrition (PN) and intravenous (IV) fluid volume in adult subjects with short bowel syndrome.

1 Nov 2011

New computer-based tool enables early diagnosis of cancer

A computer-based tool could help GPs to speed up the diagnosis and treatment of patients suffering from two of the most common forms of cancer, potentially saving thousands of lives every year.

31 Oct 2011

Hormones influence dietary and behavioral changes in regulating body weight

Worldwide, there are more than 1.5 billion overweight adults, including 400 million who are obese. In Australia, it is estimated more than 50 per cent of women and 60 per cent of men are either overweight or obese.

29 Oct 2011

E-learning may not effectively improve dietary behaviors

With more people online and using smart phones, health applications or "apps" as they are popularly known are being promoted to help with everything from exercising to quitting smoking. A new review suggests that apps designed to change and improve eating habits may not make much of a difference.

28 Oct 2011

Over-the-counter 'thyroid support' supplements could be dangerous

People who use over-the-counter "thyroid support" supplements may be putting their health at risk, according to a study being presented at the annual meeting of the American Thyroid Association. The supplements contain varying amounts of two different kinds of thyroid hormones apparently derived in large part from chopped up animal thyroid glands, says the study's senior investigator, Victor Bernet, M.D., an endocrinologist at Mayo Clinic in Florida.

28 Oct 2011

CINJ experts available to discuss risk factors of pancreatic cancer

According to the American Cancer Society, pancreatic cancer is the fifth leading cancer killer in the country, with nearly 44,000 new cases expected in 2011 and more than 37,600 deaths by year's end. In New Jersey alone, an estimated 1,100 deaths are predicted this year due to the disease. The death of Steve Jobs, who suffered from a form of pancreatic cancer, has brought increased attention to the disease in recent weeks.

28 Oct 2011

Yo-yo dieting can affect appetite hormones for up to a year

A new study suggests that the ‘yo-yo’ effect that dieters experience of shedding pounds and gaining them back may be due to the persistence of hormones that drive the urge to eat even a year after weight loss.

27 Oct 2011